Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

Spironolactone (SPR) has been shown to protect diabetic cardiomyopathy (DCM), but the specific mechanisms are not fully understood. Here, we determined the cardioprotective role of SPR in diabetic mice and further explored the potential mechanisms in both in vivo and in vitro models. Streptozotocin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenjuan, Gong, Wei, He, Min, Liu, Yemei, Yang, Yeping, Wang, Meng, Wu, Meng, Guo, Shizhe, Yu, Yifei, Wang, Xuanchun, Sun, Fei, Li, Yiming, Zhou, Linuo, Qin, Shengmei, Zhang, Zhaoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204188/
https://www.ncbi.nlm.nih.gov/pubmed/30406151
http://dx.doi.org/10.1155/2018/9232065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204188/
https://www.ncbi.nlm.nih.gov/pubmed/30406151
http://dx.doi.org/10.1155/2018/9232065

Ejemplares similares